Yüklüyor......
The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice
The prevalence of immune-mediated liver diseases such as autoimmune liver disease or viral hepatitis has increased in recent years, and the side effects of pre-existing treatments are a worldwide problem. Regulatory T cells (Tregs) and T helper 17 (Th17) cells play important roles in the development...
Kaydedildi:
| Yayımlandı: | Mol Med Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854585/ https://ncbi.nlm.nih.gov/pubmed/31638166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10750 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|